abstract |
The invention relates to inhibitors of plasminogen activators, such as urokinase, uPA or tPA for intra- and postoperative therapy, for the treatment of injuries and for the treatment and prophylaxis of inflammatory diseases. Suitable inhibitors are in particular PAI-1 and PAI-2. |